drugset / Trial / NCT00000324
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
Phase 2
Completed
200 enrolled
National Institute on Drug Abuse (NIDA)
Johns Hopkins University · collab
RandomizedDouble-blindTreatment
Summary
The purpose of this study is to assess the efficacy of tryptophan vs. placebo, and voucher payments vs. a control condition, in the treatment of cocaine dependence.
Timeline
- Start
- 1997-03
- Primary completion
- —
- Completion
- 2001-04
Publications
- Background Jones H.E., Johnson, R.E., Bigelow G.E., Strain E.C. Differences at treatment entry between opioid-dependent and cocaine-dependent males and females. Addictive Disorders and Their Treatment 3:110-121, 2004.
- Background Jones HE, Johnson RE, Bigelow GE, Silverman K, Mudric T, Strain EC. Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial. Am J Addict. 2004 Oct-Dec;13(5):421-37. doi: 10.1080/10550490490512753.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tryptophan | Other / unclassified | — | — |